uniQure N.V. Class Action Reminder

Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights

Apr. 4, 2026 at 5:32am

Got story updates? Submit your updates here. ›

A photorealistic studio still-life image featuring a stack of legal documents, a gavel, and a pair of reading glasses, symbolizing the legal proceedings and the impact on investors.A class action lawsuit filed on behalf of uniQure shareholders seeks to recover losses due to the company's alleged misconduct.San Diego Today

Robbins LLP has filed a class action lawsuit on behalf of investors who purchased or acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 2, 2022 and November 11, 2022. The lawsuit alleges that uniQure made false and misleading statements about its business and operations during this period.

Why it matters

This class action lawsuit is significant for uniQure shareholders, as it seeks to recover losses they may have incurred due to the company's alleged misconduct. The outcome of the case could have financial implications for both uniQure and its investors.

The details

The class action lawsuit alleges that uniQure made false and misleading statements about the company's business, operations, and prospects. Specifically, the lawsuit claims that uniQure failed to disclose material information about the development and regulatory approval process for its gene therapy product candidates.

  • The class action lawsuit was filed on April 4, 2026.
  • The lawsuit covers the period from September 2, 2022 to November 11, 2022.

The players

Robbins LLP

A law firm that has filed a class action lawsuit on behalf of uniQure shareholders.

uniQure N.V.

A biotechnology company that develops gene therapy products.

Got photos? Submit your photos here. ›

What’s next

The judge in the case will decide on the next steps, including whether to certify the class and allow the lawsuit to proceed.

The takeaway

This class action lawsuit highlights the importance of transparency and accurate disclosure for publicly traded companies. Investors who suffered losses due to uniQure's alleged misconduct may be able to recover those losses through this legal action.